RecruitingPhase 3NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Bennington, VT · +40 more sites
Alzheimer's Disease clinical trials in Bennington, VT
2 recruiting alzheimer's disease studies with a site in Bennington, VT.
All trials in Bennington, VT · All Alzheimer's Disease trials
RecruitingPhase 2 / Phase 3NCT07284472
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Sponsor: Exciva GmbH
Bennington, VT · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.